XPeng: Q4 Net Profit, Leading Gross Margins, Cheap

XPeng delivered its first-ever GAAP net profit in Q4, signaling a material turnaround. Revenue rose 38.2% year-over-year to $3.18B, driven by strong delivery momentum for the Mona brand; margins contracted slightly to 13%. An analyst reaffirmed a buy rating on XPEV, citing an upside risk skew from continued delivery growth.

Analysis

The profitability inflection materially changes XPEV’s optionality as a growth company: it converts execution risk into a capital-allocation story. Management can now direct incremental cash to higher-return levers (software/ADAS development, selective price support, or faster geographic expansion) rather than dilutive equity raises, which compresses the probability mass toward upside in a 6–18 month window.

Second-order winners include cell and battery-component suppliers that can negotiate multi-period offtake contracts with XPEV; those suppliers gain demand visibility and pricing leverage, while small tier-1 chassis/ICE suppliers face secular demand erosion. A sustained volume runway also raises the odds of XPEV securing preferential access to scarce battery chemistries, lowering unit costs after a 9–15 month procurement/qualification lag.

Key near-term catalysts are delivery cadence, ASP trajectory, and the next software/feature monetization announcement — each can move the re-rating over weeks to months. Tail risks that would reverse the set-up include abrupt ASP erosion from competitive discounting, a large-scale recall/OTA regression that hurts brand trust, or a material rollback of China export/regulatory support; any of these compress upside quickly within 1–3 months.

The consensus buy case undervalues two dynamics: (1) upside optionality from higher-margin software and export markets that can compound FCF beyond vehicle sales, and (2) the fragility of margin expansion to price competition. Positioning should therefore be asymmetric: capture upside with limited-definition longs (time-limited options or staged equity) while hedging cyclic margin or market-risk exposures.

Key Decisions for Investors

• Long XPEV equity (2% NAV) entered on sub-5% intraday pullback ahead of the next delivery/earnings read — target +50% in 12 months, hard stop -25% to protect thesis if ASPs roll over.
• Buy 12–18 month OTM call spread on XPEV (long call ~25% OTM, short call ~80–120% OTM) sized to 0.75–1% NAV to express asymmetric upside for a capped premium; expects 3–6x payoff if delivery and software monetization accelerate.
• Pair trade: long XPEV / short NIO (equal $ exposure) for 6–12 months to isolate execution/volume re-rating versus margin squeeze risk — pair reduces market beta while capturing share shift.
• Hedge: buy 3–6 month put protection on XPEV (or reduce size) if ASP indicators or wholesale inventory prints worsen; cost of hedging justified if downside >25% probability in next quarter.